Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 and Older With Asthma

Study Title
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromaxֲ® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Teva Identifier
ABS-AS-301
ClinicalTrials.gov Identifier
NCT01424813
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Placebo MDPI | Drug: Albuterol MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
12/01/2012 - 11/01/2013
Phase
Phase 3

Study Type

Interventional